NASDAQ:VIVO
Meridian Bioscience, Inc.
- Stock
Last Close
33.97
30/01 21:00
Market Cap
1.49B
Beta: -
Volume Today
5.63M
Avg: 686.61K
PE Ratio
−551.87
PFCF: 42.66
Sep '13 | Sep '14 | Sep '15 | Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 33.26M - | 35.16M 5.73% | 35.66M 1.40% | 40.44M 13.41% | 43.27M 7.02% | 41.74M 3.54% | 40.80M 2.25% | 50.44M 23.61% | 69.05M 36.90% | 72.33M 4.74% | |
average payables | 5.69M - | 5.28M 7.27% | 5.81M 9.98% | 7.14M 22.92% | 7.67M 7.52% | 6.99M 8.91% | 6.75M 3.44% | 9.60M 42.30% | 11.84M 23.24% | 14.73M 24.46% | |
average receivables | 25.18M - | 24.71M 1.89% | 24.74M 0.14% | 26.68M 7.82% | 28.10M 5.35% | 30.72M 9.31% | 33.97M 10.58% | 37.06M 9.09% | 46.04M 24.23% | 50.40M 9.47% | |
book value per share | 3.76 - | 3.88 3.29% | 3.98 2.50% | 3.96 0.48% | 4.02 1.44% | 4.14 3.10% | 4.49 8.23% | 5.78 28.81% | 7.59 31.34% | 8.51 12.11% | |
capex per share | -0.08 - | -0.17 112.49% | -0.11 32.30% | -0.10 16.66% | -0.11 11.09% | -0.10 6.26% | -0.09 10.14% | -0.08 13.69% | -0.42 449.89% | -0.20 52.95% | |
capex to depreciation | -0.58 - | -1.26 116.01% | -0.91 27.48% | -0.60 33.82% | -0.55 8.93% | -0.53 3.65% | -0.38 28.12% | -0.24 36.19% | -1.20 392.66% | -0.52 56.44% | |
capex to operating cash flow | -0.07 - | -0.18 148.15% | -0.11 39.19% | -0.11 3.34% | -0.11 0.42% | -0.12 11.81% | -0.11 12.26% | -0.07 35.11% | -0.27 298.27% | -0.10 61.81% | |
capex to revenue | -0.02 - | -0.04 113.51% | -0.02 34.06% | -0.02 16.49% | -0.02 8.96% | -0.02 11.59% | -0.02 3.97% | -0.01 31.15% | -0.06 342.93% | -0.03 55.09% | |
cash per share | 1.07 - | 1.04 3.33% | 1.20 15.52% | 1.12 6.29% | 1.35 20.34% | 1.41 4.38% | 1.47 3.80% | 1.25 14.80% | 1.15 7.86% | 1.88 63.66% | |
days of inventory on hand | 187.97 - | 180.97 3.72% | 179.21 0.97% | 240.81 34.37% | 199.44 17.18% | 184.42 7.53% | 174.87 5.18% | 229.54 31.26% | 240.24 4.66% | 171.10 28.78% | |
days payables outstanding | 30.17 - | 25.32 16.09% | 33.25 31.34% | 40.76 22.58% | 37.10 8.98% | 27.49 25.90% | 31.95 16.21% | 44.84 40.36% | 36.58 18.42% | 44.81 22.49% | |
days sales outstanding | 50.65 - | 44.91 11.34% | 49.18 9.53% | 50.45 2.57% | 52.91 4.89% | 55.26 4.44% | 64.66 17.00% | 55.41 14.29% | 61.51 10.99% | 51.77 15.83% | |
debt to assets | 0.12 - | 0.09 26.81% | 0.09 5.70% | 0.34 256.83% | 0.32 5.27% | 0.30 5.88% | 0.41 36.77% | 0.39 5.88% | 0.27 30.59% | 0.21 23.99% | |
debt to equity | 0.14 - | 0.10 29.46% | 0.10 6.29% | 0.51 388.51% | 0.47 7.77% | 0.43 8.43% | 0.70 62.67% | 0.64 9.63% | 0.37 41.90% | 0.26 30.18% | |
dividend yield | 0.03 - | 0.04 38.81% | 0.05 4.81% | 0.04 11.32% | 0.04 3.13% | 0.03 15.87% | 0.03 22.38% | ||||
earnings yield | 0.04 - | 0.05 21.36% | 0.05 5.31% | 0.04 20.28% | 0.04 10.15% | 0.04 6.69% | 0.06 58.30% | 0.06 5.17% | 0.09 35.17% | 0.03 63.72% | |
enterprise value | 929.93M - | 690.29M 25.77% | 662.40M 4.04% | 821.51M 24.02% | 600.86M 26.86% | 615.98M 2.52% | 417.43M 32.23% | 744.78M 78.42% | 848.45M 13.92% | 1.31B 54.81% | |
enterprise value over ebitda | 14.76 - | 11.97 18.93% | 10.99 8.20% | 14.12 28.53% | 13.01 7.89% | 15.47 18.90% | 9.60 37.91% | 9.87 2.73% | 7.88 20.08% | 18.24 131.33% | |
ev to operating cash flow | 20.93 - | 18.04 13.79% | 15.47 14.23% | 22.07 42.63% | 14.53 34.17% | 17.71 21.89% | 11.65 34.22% | 15.52 33.25% | 12.69 18.26% | 15.95 25.68% | |
ev to sales | 4.93 - | 3.66 25.83% | 3.40 7.00% | 4.19 23.23% | 2.99 28.57% | 2.88 3.63% | 2.08 28.00% | 2.94 41.39% | 2.67 9.10% | 3.94 47.78% | |
free cash flow per share | 1.00 - | 0.75 24.47% | 0.91 21.11% | 0.79 13.41% | 0.87 10.58% | 0.72 17.36% | 0.75 4.14% | 1.04 38.54% | 1.12 7.66% | 1.70 51.89% | |
free cash flow yield | 0.04 - | 0.04 0.90% | 0.05 25.29% | 0.04 23.24% | 0.06 49.16% | 0.05 20.05% | 0.08 62.19% | 0.06 22.57% | 0.06 4.99% | 0.05 7.32% | |
graham net net | 1.45 - | 1.50 3.92% | 1.68 12.04% | 0.11 93.31% | 0.46 309.60% | 0.69 48.84% | -0.60 187.61% | -1.04 73.08% | 0.16 115.43% | 1.29 702.39% | |
graham number | 8.84 - | 8.56 3.13% | 8.74 2.15% | 8.27 5.40% | 6.80 17.80% | 7.25 6.63% | 7.60 4.89% | 11.84 55.69% | 16.79 41.83% | 13.71 18.35% | |
income quality | 1.17 - | 1.10 5.74% | 1.20 9.37% | 1.15 4.12% | 1.92 66.10% | 1.46 23.97% | 1.47 0.76% | 1.04 29.32% | 0.94 9.85% | 1.94 107.15% | |
intangibles to total assets | 0.18 - | 0.18 0.63% | 0.15 11.95% | 0.36 136.35% | 0.33 10.39% | 0.31 5.36% | 0.46 48.49% | 0.49 6.05% | 0.44 9.23% | 0.41 6.98% | |
interest coverage | 57.28 - | 22.77 60.25% | 20.78 8.73% | 16.81 19.09% | 23.30 38.59% | 49.54 112.62% | 45.75 7.66% | ||||
interest debt per share | 1.41 - | 1.33 5.41% | 1.22 8.45% | 1.83 49.55% | 1.71 6.44% | 1.57 8.30% | 0.74 52.59% | ||||
inventory turnover | 1.94 - | 2.02 3.87% | 2.04 0.98% | 1.52 25.58% | 1.83 20.74% | 1.98 8.14% | 2.09 5.46% | 1.59 23.81% | 1.52 4.45% | 2.13 40.41% | |
invested capital | 0.35 - | 0.32 8.08% | 0.29 11.23% | 0.40 38.80% | 0.29 28.18% | 0.20 29.58% | 0.08 58.11% | ||||
market cap | 974.21M - | 733.34M 24.72% | 712.37M 2.86% | 810.37M 13.76% | 603.29M 25.55% | 625.56M 3.69% | 404.00M 35.42% | 727.68M 80.12% | 832.30M 14.38% | 1.36B 63.88% | |
net current asset value | 92.39M - | 96.85M 4.83% | 105.44M 8.88% | 41.44M 60.70% | 53.68M 29.54% | 63.09M 17.53% | 10.25M 83.75% | 4.56M 55.53% | 71.39M 1,466.19% | 115.56M 61.88% | |
net debt to ebitda | -0.70 - | -0.75 6.17% | -0.83 11.06% | 0.19 123.09% | -0.05 127.43% | -0.24 358.34% | 0.31 228.37% | 0.23 26.68% | 0.15 33.74% | -0.70 567.19% | |
net income per share | 0.92 - | 0.84 9.15% | 0.85 1.79% | 0.77 10.07% | 0.51 33.40% | 0.56 10.27% | 0.57 1.64% | 1.08 88.17% | 1.65 53.16% | 0.98 40.54% | |
operating cash flow per share | 1.08 - | 0.92 14.37% | 1.03 11.34% | 0.89 13.78% | 0.98 10.63% | 0.82 16.16% | 0.84 2.42% | 1.12 33.01% | 1.55 38.07% | 1.90 23.18% | |
payables turnover | 12.10 - | 14.42 19.18% | 10.98 23.86% | 8.95 18.42% | 9.84 9.87% | 13.28 34.95% | 11.42 13.95% | 8.14 28.75% | 9.98 22.59% | 8.15 18.36% | |
receivables turnover | 7.21 - | 8.13 12.79% | 7.42 8.70% | 7.23 2.51% | 6.90 4.66% | 6.60 4.25% | 5.65 14.53% | 6.59 16.68% | 5.93 9.90% | 7.05 18.80% | |
research and ddevelopement to revenue | 0.06 - | 0.07 16.27% | 0.06 2.67% | 0.07 8.90% | 0.08 10.85% | 0.08 1.14% | 0.09 13.04% | 0.09 4.77% | 0.08 19.59% | 0.07 2.85% | |
return on tangible assets | 0.26 - | 0.24 8.87% | 0.23 3.70% | 0.20 12.14% | 0.13 36.36% | 0.14 7.14% | 0.14 0.86% | 0.22 60.37% | 0.28 28.10% | 0.16 45.28% | |
revenue per share | 4.58 - | 4.56 0.48% | 4.68 2.67% | 4.67 0.20% | 4.76 1.96% | 5.05 6.03% | 4.72 6.42% | 5.92 25.36% | 7.35 24.15% | 7.70 4.76% | |
roe | 0.25 - | 0.22 12.04% | 0.21 0.69% | 0.19 9.64% | 0.13 34.34% | 0.14 6.95% | 0.13 6.09% | 0.19 46.08% | 0.22 16.62% | 0.12 46.96% | |
roic | 0.46 - | 0.41 11.58% | 0.47 15.98% | 0.22 53.72% | 0.17 20.80% | 0.20 14.16% | 0.13 33.85% | 0.17 27.77% | 0.22 30.04% | 0.15 30.62% | |
sales general and administrative to revenue | 0.16 - | 0.15 10.33% | 0.14 2.28% | 0.16 9.97% | 0.16 5.58% | 0.16 1.88% | 0.17 6.55% | 0.18 6.37% | 0.16 10.03% | 0.17 4.22% | |
shareholders equity per share | 3.76 - | 3.88 3.29% | 3.98 2.50% | 3.96 0.48% | 4.02 1.44% | 4.14 3.10% | 4.49 8.23% | 5.78 28.81% | 7.59 31.34% | 8.51 12.11% | |
stock based compensation to revenue | 0.01 - | 0.02 42.06% | 0.02 9.43% | 0.01 12.98% | 0.02 13.43% | 0.02 5.41% | 0.02 1.53% | 0.01 7.33% | 0.01 12.77% | 0.02 58.49% | |
tangible asset value | 123.87M - | 130.02M 4.96% | 137.59M 5.82% | 74.64M 45.76% | 87.95M 17.85% | 97.67M 11.04% | 41.48M 57.53% | 50.25M 21.12% | 129.48M 157.70% | 177.63M 37.18% | |
tangible book value per share | 3.00 - | 3.14 4.38% | 3.30 5.30% | 1.78 46.21% | 2.08 17.35% | 2.31 10.68% | 0.97 57.77% | 1.17 20.32% | 2.99 155.29% | 4.11 37.18% | |
working capital | 92.39M - | 99.01M 7.17% | 107.60M 8.67% | 104.22M 3.14% | 110.99M 6.49% | 114.88M 3.51% | 123.85M 7.81% | 109.67M 11.45% | 145.65M 32.81% | 152.65M 4.80% |
All numbers in USD (except ratios and percentages)